-
1
-
-
38549092093
-
Aldosterone and vascular inflammation
-
Brown N.J. Aldosterone and vascular inflammation. Hypertension 2008, 51:161-167.
-
(2008)
Hypertension
, vol.51
, pp. 161-167
-
-
Brown, N.J.1
-
2
-
-
0142087611
-
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells
-
Calabro P., Willerson J.T., Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108:1930-1932.
-
(2003)
Circulation
, vol.108
, pp. 1930-1932
-
-
Calabro, P.1
Willerson, J.T.2
Yeh, E.T.3
-
4
-
-
0036796624
-
Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy
-
Farquharson C.A., Struthers A.D. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin. Sci. (Lond.) 2002, 103:425-431.
-
(2002)
Clin. Sci. (Lond.)
, vol.103
, pp. 425-431
-
-
Farquharson, C.A.1
Struthers, A.D.2
-
5
-
-
0031887627
-
Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction
-
Florian J.A., Watts S.W. Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J. Pharmacol. Exp. Ther 1998, 284:346-355.
-
(1998)
J. Pharmacol. Exp. Ther
, vol.284
, pp. 346-355
-
-
Florian, J.A.1
Watts, S.W.2
-
6
-
-
84878246840
-
Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK
-
Fu G.X., Xu C.C., Zhong Y., et al. Aldosterone-induced osteopontin expression in vascular smooth muscle cells involves MR, ERK, and p38 MAPK. Endocrine 2012, 42:676-683.
-
(2012)
Endocrine
, vol.42
, pp. 676-683
-
-
Fu, G.X.1
Xu, C.C.2
Zhong, Y.3
-
7
-
-
84894456986
-
Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness
-
Galmiche G., Pizard A., Gueret A., et al. Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness. Hypertension 2014, 63:520-526.
-
(2014)
Hypertension
, vol.63
, pp. 520-526
-
-
Galmiche, G.1
Pizard, A.2
Gueret, A.3
-
8
-
-
0035908975
-
Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation
-
Hilgers K.F., Hartner A., Porst M., et al. Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation. Circulation 2001, 104:1436-1440.
-
(2001)
Circulation
, vol.104
, pp. 1436-1440
-
-
Hilgers, K.F.1
Hartner, A.2
Porst, M.3
-
9
-
-
0142200902
-
C-reactive protein directly inhibits nitric oxide production by cytokine-stimulated vascular smooth muscle cells
-
Ikeda U., Takahashi M., Shimada K. C-reactive protein directly inhibits nitric oxide production by cytokine-stimulated vascular smooth muscle cells. J. Cardiovasc. Pharmacol 2003, 42:607-611.
-
(2003)
J. Cardiovasc. Pharmacol
, vol.42
, pp. 607-611
-
-
Ikeda, U.1
Takahashi, M.2
Shimada, K.3
-
10
-
-
0141727734
-
Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue
-
Jabs W.J., Theissing E., Nitschke M., et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003, 108:1428-1431.
-
(2003)
Circulation
, vol.108
, pp. 1428-1431
-
-
Jabs, W.J.1
Theissing, E.2
Nitschke, M.3
-
11
-
-
16444375794
-
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells
-
Jaffe I.Z., Mendelsohn M.E. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ. Res 2005, 96:643-650.
-
(2005)
Circ. Res
, vol.96
, pp. 643-650
-
-
Jaffe, I.Z.1
Mendelsohn, M.E.2
-
12
-
-
34247209264
-
Mineralocorticoid receptor activation promotes vascular cell calcification
-
Jaffe I.Z., Tintut Y., Newfell B.G., et al. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler. Thromb. Vasc. Biol 2007, 27:799-805.
-
(2007)
Arterioscler. Thromb. Vasc. Biol
, vol.27
, pp. 799-805
-
-
Jaffe, I.Z.1
Tintut, Y.2
Newfell, B.G.3
-
13
-
-
58149510602
-
Aldosterone activates NF-kappaB in the collecting duct
-
Leroy V., De Seigneux S., Agassiz V., et al. Aldosterone activates NF-kappaB in the collecting duct. J. Am. Soc. Nephrol 2009, 20:131-144.
-
(2009)
J. Am. Soc. Nephrol
, vol.20
, pp. 131-144
-
-
Leroy, V.1
De Seigneux, S.2
Agassiz, V.3
-
14
-
-
77949988816
-
Toll-like receptor 4 signaling mediates inflammatory activation induced by C-reactive protein in vascular smooth muscle cells
-
Liu N., Liu J.T., Ji Y., et al. Toll-like receptor 4 signaling mediates inflammatory activation induced by C-reactive protein in vascular smooth muscle cells. Cell. Physiol. Biochem 2010, 25:467-476.
-
(2010)
Cell. Physiol. Biochem
, vol.25
, pp. 467-476
-
-
Liu, N.1
Liu, J.T.2
Ji, Y.3
-
15
-
-
79961166769
-
C-reactive protein induces TNF-alpha secretion by p38 MAPK-TLR4 signal pathway in rat vascular smooth muscle cells
-
Liu N., Liu J.T., Ji Y., et al. C-reactive protein induces TNF-alpha secretion by p38 MAPK-TLR4 signal pathway in rat vascular smooth muscle cells. Inflammation 2011, 34:283-290.
-
(2011)
Inflammation
, vol.34
, pp. 283-290
-
-
Liu, N.1
Liu, J.T.2
Ji, Y.3
-
16
-
-
33751110231
-
Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism
-
Luther J.M., Gainer J.V., Murphey L.J., et al. Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension 2006, 48:1050-1057.
-
(2006)
Hypertension
, vol.48
, pp. 1050-1057
-
-
Luther, J.M.1
Gainer, J.V.2
Murphey, L.J.3
-
17
-
-
2942608911
-
Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells
-
Mazak I., Fiebeler A., Muller D.N., et al. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 2004, 109:2792-2800.
-
(2004)
Circulation
, vol.109
, pp. 2792-2800
-
-
Mazak, I.1
Fiebeler, A.2
Muller, D.N.3
-
18
-
-
31544473558
-
Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells
-
Miyata K., Rahman M., Shokoji T., et al. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J. Am. Soc. Nephrol 2005, 16:2906-2912.
-
(2005)
J. Am. Soc. Nephrol
, vol.16
, pp. 2906-2912
-
-
Miyata, K.1
Rahman, M.2
Shokoji, T.3
-
19
-
-
84893869723
-
Aldosterone synthase inhibitors in cardiovascular and renal diseases
-
Namsolleck P., Unger T. Aldosterone synthase inhibitors in cardiovascular and renal diseases. Nephrol. Dial. Transplant 2014, 29(Suppl. 1):i62-i68.
-
(2014)
Nephrol. Dial. Transplant
, vol.29
, Issue.Suppl. 1
-
-
Namsolleck, P.1
Unger, T.2
-
20
-
-
0034739462
-
Direct proinflammatory effect of C-reactive protein on human endothelial cells
-
Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
-
(2000)
Circulation
, vol.102
, pp. 2165-2168
-
-
Pasceri, V.1
Willerson, J.T.2
Yeh, E.T.3
-
21
-
-
0035967470
-
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs
-
Pasceri V., Cheng J.S., Willerson J.T., et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001, 103:2531-2534.
-
(2001)
Circulation
, vol.103
, pp. 2531-2534
-
-
Pasceri, V.1
Cheng, J.S.2
Willerson, J.T.3
-
22
-
-
79959871432
-
Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells
-
Rautureau Y., Paradis P., Schiffrin E.L. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells. Steroids 2011, 76:834-839.
-
(2011)
Steroids
, vol.76
, pp. 834-839
-
-
Rautureau, Y.1
Paradis, P.2
Schiffrin, E.L.3
-
23
-
-
0037469177
-
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
-
Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
-
(2003)
Circulation
, vol.107
, pp. 363-369
-
-
Ridker, P.M.1
-
25
-
-
79960612316
-
Transcriptome analysis of aldosterone-regulated genes in human vascular endothelial cell lines stably expressing mineralocorticoid receptor
-
Sekizawa N., Yoshimoto T., Hayakawa E., et al. Transcriptome analysis of aldosterone-regulated genes in human vascular endothelial cell lines stably expressing mineralocorticoid receptor. Mol. Cell. Endocrinol 2011, 341:78-88.
-
(2011)
Mol. Cell. Endocrinol
, vol.341
, pp. 78-88
-
-
Sekizawa, N.1
Yoshimoto, T.2
Hayakawa, E.3
-
26
-
-
0029788193
-
Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin
-
Takeda Y., Miyamori I., Yoneda T., et al. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J. Clin. Endocrinol. Metab 1996, 81:2797-2800.
-
(1996)
J. Clin. Endocrinol. Metab
, vol.81
, pp. 2797-2800
-
-
Takeda, Y.1
Miyamori, I.2
Yoneda, T.3
-
27
-
-
0037126012
-
Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells
-
Venugopal S.K., Devaraj S., Yuhanna I., et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106:1439-1441.
-
(2002)
Circulation
, vol.106
, pp. 1439-1441
-
-
Venugopal, S.K.1
Devaraj, S.2
Yuhanna, I.3
-
28
-
-
0037161360
-
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein
-
Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896.
-
(2002)
Circulation
, vol.105
, pp. 1890-1896
-
-
Verma, S.1
Li, S.H.2
Badiwala, M.V.3
-
29
-
-
0037426399
-
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle
-
Wang C.H., Li S.H., Weisel R.D., et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003, 107:1783-1790.
-
(2003)
Circulation
, vol.107
, pp. 1783-1790
-
-
Wang, C.H.1
Li, S.H.2
Weisel, R.D.3
-
30
-
-
84896275736
-
Inflammatory mechanisms in atherosclerosis
-
Wolf D., Stachon P., Bode C., et al. Inflammatory mechanisms in atherosclerosis. Hamostaseologie 2014, 34:63-71.
-
(2014)
Hamostaseologie
, vol.34
, pp. 63-71
-
-
Wolf, D.1
Stachon, P.2
Bode, C.3
-
31
-
-
84863658156
-
The mineralocorticoid receptor-p38MAPK-NFkappaB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells
-
Zhu C.J., Wang Q.Q., Zhou J.L., et al. The mineralocorticoid receptor-p38MAPK-NFkappaB or ERK-Sp1 signal pathways mediate aldosterone-stimulated inflammatory and profibrotic responses in rat vascular smooth muscle cells. Acta Pharmacol. Sin 2012, 33:873-878.
-
(2012)
Acta Pharmacol. Sin
, vol.33
, pp. 873-878
-
-
Zhu, C.J.1
Wang, Q.Q.2
Zhou, J.L.3
-
32
-
-
0035814966
-
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis
-
Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001, 103:1194-1197.
-
(2001)
Circulation
, vol.103
, pp. 1194-1197
-
-
Zwaka, T.P.1
Hombach, V.2
Torzewski, J.3
|